|
Report No. : |
318771 |
|
Report Date : |
29.04.2015 |
IDENTIFICATION DETAILS
|
Name : |
NERHADOU INTERNATIONAL FOR PHARMACEUTICALS & NUTRACEUTICALS |
|
|
|
|
Registered Office : |
Block 1/15, Building 2, District 11, West Sumed, 6th of October City, Giza, Cairo |
|
|
|
|
Country : |
Egypt |
|
|
|
|
Date of Incorporation : |
25.03.1996 |
|
|
|
|
Com. Reg. No.: |
107738 |
|
|
|
|
Legal Form : |
Egyptian Joint Stock Company |
|
|
|
|
Line of Business : |
Engaged in the production and distribution of vitamins, hormones, hair and skin care products. |
|
|
|
|
No of Employees : |
300 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made on
e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2014
|
Country Name |
Previous Rating (30.09.2014) |
Current Rating (31.12.2014) |
|
Egypt |
B2 |
B2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderate Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderate High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
EGYPT ECONOMIC OVERVIEW
Occupying the northeast corner of the African continent, Egypt is bisected by the highly fertile Nile valley, where most economic activity takes place. Egypt's economy was highly centralized during the rule of former President Gamal Abdel NASSER but opened up considerably under former Presidents Anwar EL-SADAT and Mohamed Hosni MUBARAK. Cairo from 2004 to 2008 pursued business climate reforms to attract foreign investment and facilitate growth. Poor living conditions and limited job opportunities for the average Egyptian contribute to public discontent, a major factor leading to the January 2011 revolution that ousted Mubarak. The uncertain political, security, and policy environment since 2011 caused economic growth to slow significantly, hurting tourism, manufacturing, and other sectors and pushing up unemployment. Weak growth and limited foreign exchange earnings have made public finances unsustainable, leaving authorities dependent on expensive borrowing for deficit finance and on Gulf allies to help cover the import bill.
|
Source
: CIA |
Company Name : NERHADOU INTERNATIONAL FOR PHARMACEUTICALS &
NUTRACEUTICALS
Also Known As : NERHADOU INTERNATIONAL MOHSEN SHALABY AND PARTNERS
Country of Origin : Egypt
Legal Form : Egyptian Joint Stock Company
Registration Date : 25th March 1996
Commercial Registration Number : 107738
Issued Capital : £E 2,500,000
Paid up Capital : £E 2,500,000
Total Workforce : 300
Activities : Production and distribution of vitamins, hormones, hair and skin care
products.
Financial Condition : Undetermined
Payments : Nothing detrimental uncovered
Person Interviewed : Maged Taher, Finance Manager
COMPANY NAME: NERHADOU INTERNATIONAL FOR PHARMACEUTICALS
& NUTRACEUTICALS
ALSO KNOWN AS: NERHADOU INTERNATIONAL MOHSEN SHALABY AND
PARTNERS
Building : Block 1/15, Building 2
Area : District 11, West Sumed, 6th
of October City, Giza
Town : Cairo
Country : Egypt
Telephone : (20-2) 38381702 / 38381703
Facsimile : (20-2) 38361708
Email : info@nerhadou.com
Subject operates from
a large suite of offices and a factory that are rented and located in the
Industrial Area of Cairo.
Branch Office
(s)
Location Description
·
11
Lebanon Street Rented
office and warehouse premises
Mohandessin
Giza
Cairo
·
9 Amed Samy
Street Rented
office and warehouse premises
Mohandessin
Giza
Cairo
·
4 El
Sbahy Street Rented
office and warehouse premises
El Omranyia
Giza
Cairo
·
4 Al
Yosser Street Rented
office and warehouse premises
Dokki
Giza
Cairo
Name Position
·
Mohsen
Mohamed Mahmoud Shalaby Chairman
·
Reham
Mohsen Mohamed Mahmoud Shalaby Vice
Chairman
·
Nirvana
Mohsen Mohamed Mahmoud Shalaby Director
·
Mohy
Mohsen Mohamed Mahmoud Shalaby Chief
Executive Officer
·
Maged
Taher Finance
Manager
·
Madiha
Mohsen Mohamed Mahmoud Shalaby Human
Resources Manager
Date of Establishment : 25th
March 1996
Legal Form :
Egyptian Joint Stock
Company
Commercial Reg. No. : 107738
Issued Capital : £E 2,500,000
Paid up Capital : £E 2,500,000
·
Mohsen
Mohamed Mahmoud Shalaby
·
Reham
Mohsen Mohamed Mahmoud Shalaby
·
Nirvana
Mohsen Mohamed Mahmoud Shalaby
·
Mohy
Mohsen Mohamed Mahmoud Shalaby
·
Local
businessmen and private investors
Activities: Engaged in the production and distribution
of vitamins, hormones, hair and skin care products.
Import
Countries: Germany, China
and the United Kingdom.
Suppliers:
·
Alcina
·
Alpecin
·
Sigma
Pharmaceutical Industries
·
Jedco International
Pharmaceutical Co
·
EIMC
United Pharmaceuticals
Local Clients:
·
Egyptian
Pharmaceutical Trading Co
Brand Names: CALCITRON, FERROTRON, ZINCTRON,
HI-POTENCY, TRIB GOLD, ALPECIN and ALCINA
Subject has a
workforce of approximately 300 employees.
Companies
registered in Egypt are not legally required to make their accounts public and
no financial information was released by the company or submitted by outside
sources.
·
QNB Al
Ahli Bank
30 Lebanon Street
Mohandessin
Giza
Cairo
No complaints
regarding subject’s payments have been reported.
During the course
of this investigation nothing detrimental was uncovered regarding subject’s
operating history or the manner in which payments are fulfilled. As such the
company is considered to be a fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 63.33 |
|
|
1 |
Rs. 96.51 |
|
Euro |
1 |
Rs. 68.92 |
INFORMATION DETAILS
|
Analysis Done by
: |
KRN |
|
|
|
|
Report Prepared
by : |
DPT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to
overcome financial difficulties seems comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment record
(10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.